featured
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis
JAMA Dermatol 2024 Aug 07;[EPub Ahead of Print], CM Boesjes, E Kamphuis, M de Graaf, LS Spekhorst, I Haeck, LF van der Gang, L Loman, NPA Zuithoff, C Dekkers, LP van der Rijst, GLE Romeijn, AJ Oosting, A Gostynksi, AMT van Lynden-van Nes, RA Tupker, AM van Tuyll van Serooskerken, A Flinterman, K Politiek, WRH Touwslager, WA Christoffers, SM Stewart, M Kamsteeg, MA Schuttelaar, MS de Bruin-WellerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.